The abuse deterrent formulation (ADF) platform technology
Safe, tailored and innovative controlled release formulations to protect your product and patient.
- Deters various routes of abuse, including injection and solvent extraction.
- Versatile platform – can be tailored for multiple administration routes – oral, sublingual and parenteral.
- Tested and proven across a range of compounds of varying solubility levels, including Opioids.
- In-vitro bioequivalence of the tablet formulation to RLD (Reference Listed Drug).
- Advanced controlled release – a range of release profiles and triggers.
- Intelligent design, developed with the patient in mind – flexible dosage form (powder/tablets/suspensions).